Beijing Biostar Pharmaceuticals Co., Ltd. Class H(HK:2563)
HK$3.490.00 (0.00%)
HK:2563
Beijing Biostar Pharmaceuticals Co., Ltd. Class H financials statements
HK$3.49
At close:0.00 (0.00%)
Want to see HK:2563 full AI Analyst Report?
Beijing Biostar Pharmaceuticals Co., Ltd. Class H (2563) Income Statement
0 Followers
Beijing Biostar Pharmaceuticals Co., Ltd. Class H Income Statement
Last quarter (Q2 2026), Beijing Biostar Pharmaceuticals Co., Ltd. Class H's total revenue was HK$21.16M, a decrease of 3.51% from the same quarter last year. In Q2, Beijing Biostar Pharmaceuticals Co., Ltd. Class H's net income was HK$-15.36M. See Beijing Biostar Pharmaceuticals Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Jun 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| HK$ 37.12M | HK$ 77.92M | HK$ 73.75M | HK$ 37.38M | HK$ 106.74M | |
| HK$ 33.65M | HK$ 66.75M | HK$ 51.83M | HK$ 27.20M | HK$ 100.48M | |
| HK$ 183.68M | HK$ 218.02M | HK$ 293.09M | HK$ 255.14M | HK$ 511.93M | |
| Depreciation and Amortization | HK$ 11.62M | HK$ 10.54M | HK$ 11.76M | HK$ 11.96M | HK$ 10.66M |
| HK$ -139.77M | HK$ -173.84M | HK$ -198.08M | HK$ -170.77M | HK$ -430.65M | |
| HK$ -151.39M | HK$ -184.38M | HK$ -241.26M | HK$ -227.94M | HK$ -411.45M | |
| HK$ 8.84M | HK$ 28.49M | HK$ 31.36M | HK$ 45.13M | HK$ -6.34M | |
| HK$ -142.54M | HK$ -155.89M | HK$ -209.90M | HK$ -182.81M | HK$ -417.79M | |
| HK$ -142.54M | HK$ -155.89M | HK$ -209.90M | HK$ -182.81M | HK$ -417.79M | |
| Per Share Metrics | |||||
| Basic EPS | HK$ -0.39 | HK$ -0.43 | HK$ -0.58 | HK$ -0.50 | HK$ -1.19 |
| Diluted EPS | HK$ -0.39 | HK$ -0.43 | HK$ -0.58 | HK$ -0.50 | HK$ -1.19 |
| Weighted Average Shares Outstanding | 365.10M | 364.59M | 364.59M | 364.59M | 350.00M |
| Weighted Average Shares Outstanding (Diluted) | 365.10M | 364.59M | 364.59M | 364.59M | 350.00M |
Currency in HKD

